A supplement called NMN may help treat PCOS by improving how ovary cells produce energy, according to Gram Research analysis of a 2026 study. Researchers found that NMN reversed insulin resistance, hormone imbalances, irregular periods, and abnormal ovary structure in rats with PCOS by activating a protein pathway that restores energy production in ovary cells. However, this research is still in early stages using animals and lab cells, not humans, so NMN cannot yet be recommended as a PCOS treatment.
Researchers discovered that a supplement called NMN (nicotinamide mononucleotide) may help treat polycystic ovary syndrome, or PCOS, a common hormone disorder affecting millions of women. According to Gram Research analysis, the study found that NMN works by fixing how cells in the ovaries process energy, which helps reduce insulin resistance and hormone imbalances. Scientists tested this in rats with PCOS and in human ovary cells in the lab, finding that NMN reversed several PCOS symptoms including irregular periods and abnormal ovary structure. While these results are promising, the research is still in early stages and hasn’t been tested in women yet.
Key Statistics
A 2026 study published in the International Journal of Biological Macromolecules found that NMN supplementation reversed polycystic ovary syndrome symptoms in rats, including restoring regular menstrual cycles and reducing abnormal ovary structure within 30 days of treatment.
Researchers identified that NMN works by activating a protein called SIRT2, which removes a chemical modification from the energy-producing enzyme LDHA, thereby restoring proper energy production in ovary cells affected by PCOS.
The study demonstrated that NMN increased NAD+ levels in ovaries and enhanced glycolytic activity, the cellular process that generates energy, while simultaneously reducing insulin resistance and testosterone levels in PCOS rats.
The Quick Take
- What they studied: Whether a supplement called NMN can help treat PCOS by improving how ovary cells use energy and process hormones
- Who participated: Rats that were given drugs and a high-fat diet to create PCOS symptoms, plus human ovary cells grown in a laboratory
- Key finding: NMN supplementation reversed insulin resistance, hormone imbalances, irregular periods, and abnormal ovary structure in rats with PCOS, while also boosting energy production in ovary cells
- What it means for you: This research suggests NMN might become a treatment option for PCOS, but it’s still in early testing stages. Women with PCOS should not start taking NMN supplements without talking to their doctor first, as human studies haven’t been completed yet
The Research Details
Scientists created PCOS in rats by giving them a drug called letrozole and feeding them a high-fat diet for 30 days. Once the rats developed PCOS symptoms, half received NMN supplements and half received a placebo for another 30 days. Researchers measured changes in insulin levels, hormone levels, ovary structure, and menstrual cycle regularity. They also studied human ovary cells in the lab to understand exactly how NMN works at the molecular level, using techniques like genetic testing and protein analysis.
The researchers focused on a specific protein called LDHA that helps cells create energy. They discovered that in PCOS, this protein gets chemically modified in a way that makes it work poorly. NMN appears to reverse this modification, restoring the protein’s function.
This combination of animal testing and lab cell studies allowed scientists to both see if NMN helps PCOS symptoms and understand the exact biological mechanism behind how it works.
This research approach is important because it bridges the gap between basic science and potential treatment. By testing in both living animals and isolated cells, researchers could confirm that NMN actually works and identify the specific molecular pathway involved. This makes NMN a more credible candidate for future human trials, since scientists understand exactly how it affects the body at a cellular level.
This study was published in a peer-reviewed scientific journal, meaning other experts reviewed the work before publication. However, the research is preliminary: it was conducted in animals and lab cells, not in humans. The study was well-designed with proper controls and multiple testing methods, which strengthens the findings. The fact that researchers identified a specific molecular mechanism adds credibility. Readers should know that animal studies don’t always translate to human results, so more research is needed before NMN can be recommended as a PCOS treatment.
What the Results Show
NMN supplementation produced dramatic improvements in PCOS rats. Insulin resistance, a major problem in PCOS, was significantly reduced. Testosterone levels, which are abnormally high in PCOS, dropped to more normal ranges. The rats’ estrous cycles, which were irregular due to PCOS, became regular again. When researchers examined the ovaries under a microscope, the polycystic appearance (multiple small cysts) improved substantially.
At the cellular level, NMN increased NAD+ levels in the ovaries. NAD+ is a molecule that cells need to produce energy efficiently. The supplement also boosted glycolytic activity, meaning ovary cells could generate energy more effectively. These metabolic improvements appeared to be the key to reversing PCOS symptoms.
In human ovary cells studied in the lab, NMN had similar effects. It increased cell survival, reduced cell death, and improved energy production. The researchers traced these benefits to a specific molecular pathway involving two proteins: SIRT2 and LDHA.
The research identified a critical detail about how NMN works. Scientists discovered that SIRT2 is the protein responsible for removing a chemical tag (acetyl group) from LDHA at a specific location called K119. This removal is essential for LDHA to function properly. When this tag is present, LDHA works poorly and cells can’t generate energy efficiently. NMN appears to activate SIRT2, which then removes this tag and restores LDHA function. This finding is significant because it identifies a precise molecular target for future PCOS treatments.
Previous research has shown that PCOS involves problems with how cells use energy and process glucose. This study builds on that knowledge by identifying a specific mechanism: the SIRT2-LDHA pathway. While other studies have suggested that NAD+ boosting supplements might help metabolic disorders, this is among the first to demonstrate this effect specifically in PCOS and to identify the exact molecular pathway involved. The findings align with growing evidence that energy metabolism problems are central to PCOS development.
This study has several important limitations. First, it was conducted in rats and lab cells, not in humans. Rat studies often don’t produce the same results in people due to differences in metabolism and biology. Second, the sample size of rats wasn’t specified in the abstract, making it harder to assess statistical reliability. Third, the study didn’t test different doses of NMN or compare it to other potential treatments. Fourth, researchers didn’t evaluate long-term effects or potential side effects of NMN supplementation. Finally, the study was conducted in a controlled lab setting, which doesn’t reflect the complexity of PCOS in real women with varying genetics, diets, and lifestyles.
The Bottom Line
Based on this preclinical research, NMN cannot yet be recommended as a PCOS treatment. The evidence is promising but limited to animal and cell studies. Women with PCOS should continue following their doctor’s current treatment recommendations, which may include lifestyle changes, medications like metformin, and hormonal birth control. If and when human clinical trials of NMN for PCOS begin, interested women should discuss participation with their healthcare provider. Confidence level: Low, because human studies haven’t been conducted yet.
Women with PCOS or those at risk for PCOS should pay attention to this research as it develops. Healthcare providers treating PCOS should be aware of this emerging research direction. Researchers studying metabolic disorders and reproductive health should find this work relevant. People should not start taking NMN supplements specifically for PCOS without medical supervision, as safety and effectiveness in humans hasn’t been established. This research is most relevant to those interested in understanding PCOS biology and potential future treatments.
If NMN moves forward to human clinical trials, it would typically take 3 to 5 years to complete initial safety and effectiveness studies. Even if trials are successful, regulatory approval and availability as a PCOS treatment could take several additional years. Women should not expect NMN to become a standard PCOS treatment in the immediate future. This research represents an early step in a long development process.
Frequently Asked Questions
Can I take NMN supplements right now to treat my PCOS?
No, this research is still in early animal testing stages. Human clinical trials haven’t been completed yet, so NMN’s safety and effectiveness in women with PCOS is unknown. Talk to your doctor before taking any new supplements for PCOS.
How does NMN help with PCOS symptoms?
According to the research, NMN boosts NAD+ levels in ovary cells and activates a protein pathway that improves energy production. Better energy production in ovary cells appears to reduce insulin resistance, balance hormones, and restore regular menstrual cycles.
When will NMN be available as a PCOS treatment?
It’s too early to say. Researchers must first conduct human clinical trials to test safety and effectiveness, which typically takes 3 to 5 years. Even if successful, regulatory approval could take additional years before NMN becomes a standard PCOS treatment.
Is this research definitive proof that NMN treats PCOS?
No, this is preliminary research using rats and lab cells. While the results are promising, animal studies don’t always produce the same results in humans. Much more research, including human trials, is needed before drawing firm conclusions.
What should I do about my PCOS while waiting for NMN research to develop?
Continue working with your doctor on current PCOS treatments, which may include lifestyle changes, medications like metformin, and hormonal birth control. Stay informed about emerging research, and discuss any new treatments with your healthcare provider before trying them.
Want to Apply This Research?
- Track menstrual cycle regularity and length over 30-day periods. Record cycle start date, duration, and any symptoms like irregular bleeding. This metric directly relates to the study’s findings about restored cycle regularity.
- Once NMN becomes available for human use (if approved), users could log daily supplement intake and correlate it with energy levels, mood, and cycle regularity. The app could send reminders for consistent daily dosing and track any side effects.
- Establish a baseline of current cycle patterns and hormone-related symptoms before any intervention. Use the app to monitor changes in menstrual regularity, energy levels, and PCOS-related symptoms over 3-month periods. Share tracked data with healthcare providers to inform treatment decisions.
This article summarizes preliminary research conducted in animals and laboratory cells. The findings have not been tested in humans, and NMN is not currently approved or recommended as a PCOS treatment. Women with PCOS should not start taking NMN supplements without consulting their healthcare provider. This research represents early-stage science and should not replace established PCOS treatments or medical advice. Always discuss new supplements or treatments with your doctor before use, especially if you have PCOS or are taking medications for hormonal or metabolic conditions.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.